WHO has prequalified two Covid-19 rapid antigen tests for the first time, confirming long-term quality and enabling UN ...
An exam meant to determine whether a baby was born dead or alive is of “questionable value,” the National Association of ...
The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...
The World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for ...
In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...
WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...
WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
As the cold and flu season approaches, the rising cases of COVID-19 in the United States raise significant concerns for public health. With the holiday season bringing increased travel and gatherings, ...
On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...